| 000 | 01599 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516100206.0 | ||
| 264 | 0 | _c20130130 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1475-2875 | ||
| 024 | 7 |
_a10.1186/1475-2875-11-209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchuldt, Nathaniel J | |
| 245 | 0 | 0 |
_aImmunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and adenovirus (Ad5) immune mice. _h[electronic resource] |
| 260 |
_bMalaria journal _cJun 2012 |
||
| 300 |
_a209 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Protozoan _xgenetics |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 | _aCross Reactions |
| 650 | 0 | 4 |
_aDrug Carriers _xadministration & dosage |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
| 650 | 0 | 4 |
_aMalaria Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 650 | 0 | 4 |
_aVaccines, Synthetic _xadministration & dosage |
| 700 | 1 | _aAldhamen, Yasser A | |
| 700 | 1 | _aGodbehere-Roosa, Sarah | |
| 700 | 1 | _aSeregin, Sergey S | |
| 700 | 1 | _aKousa, Youssef A | |
| 700 | 1 | _aAmalfitano, Andrea | |
| 773 | 0 |
_tMalaria journal _gvol. 11 _gp. 209 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1475-2875-11-209 _zAvailable from publisher's website |
| 999 |
_c21884419 _d21884419 |
||